Author： Sweet R.A. Pollock B.G.
Publisher： Adis International
ISSN： 1170-229X
Source： Drugs & Aging, Vol.12, Iss.2, 1998-02, pp. : 115-127
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
The atypical antipsychotics are a new class of agents with great promise for use in the elderly because of their reduced propensity to cause acute extrapyramidal adverse effects. Treatment of older patients with these agents, however, needs to take into consideration age-related changes in pharmacokinetics and the risks of drug-drug interactions. Additionally, current evidence of their efficacy in late-life psychoses is derived largely from case series and from the extrapolation of results obtained in studies of younger patients with schizophrenia. Controlled clinical studies of atypical antipsychotics in elderly patients are urgently needed.
Related content
Conventional and Atypical Antipsychotics in the Elderly: A Review
By Gareri P.
Clinical Drug Investigation, Vol. 23, Iss. 5, 2003-01 ,pp. :
Access to resources
Recommend
New onset diabetes and atypical antipsychotics
By Liebzeit K.A. Markowitz J.S. Caley C.F.
European Neuropsychopharmacology, Vol. 11, Iss. 1, 2001-02 ,pp. :